Covigilant Research, LLC Clinical Trials Site Management Organization

Covigilant Research, LLC

Committed To Working Together

Protagonist Therapeutics Announces Removal of FDA Clinical Hold on the Rusfertide …,

All ongoing clinical trials of rusfertide to resume dosing. Phase 3 registrational trial planned to commence in the first quarter of 2022., All ongoing clinical trials of rusfertide to resume dosing. Phase 3 registrational trial planned to commence in the first quarter of 2022., Read More

Scroll to Top